Developer docs
API playgroundTry for free, no card

Search company profiles

Veterinary Immunogenics

Full company profile

uuid002rr56

Namestring
Veterinary Immunogenics
Legal namestring
Veterinary Immunogenics Ltd
Company typeenum
Private
Founded yearint
1992
Descriptiontext

Veterinary Immunogenics Ltd, operating under the Plasvacc UK brand, is a privately held veterinary biological products manufacturer founded in 1992 and headquartered in Penrith, Cumbria, United Kingdom. The company specialises in hyperimmunised equine plasma biologics marketed under the Hypermune™ and Hypermune™-RE trademarks, which are cell-free plasma products with elevated IgG antibody levels derived from a Veterinary Medicines Directorate (VMD) approved donor herd. Plasma is collected using pheresing equipment and controls comparable to those used in human blood product collection, and each product label displays measured IgG content to guarantee higher antibody levels than non-hyperimmunised alternatives. The differentiated input is 100% single-source, never-blended donor plasma, providing full traceability from donor animal to patient.

The company also offers Canine & Feline Diagnostic Kits as an add-on product line, extending its reach from equine practitioners to small animal veterinarians. Its go-to-market is sales-led, with direct ordering via phone and website contact form rather than distributor or retail channels, and technical support is delivered by experienced veterinarians who use VIL products in their own practices. Veterinary Immunogenics operates in four countries — the UK, Australia, USA, and Chile — under the unified Plasvacc brand, and is a member of five major veterinary and equine professional associations (AAEP, AAEVT, AVH, VECCS, BEVA). Revenue is generated through one-time purchases of plasma biologics and diagnostic kits, with pricing not publicly disclosed.

Short descriptiontext

Veterinary Immunogenics Ltd manufactures hyperimmunised equine plasma biologics (Hypermune™) and small animal diagnostic kits, selling directly to veterinarians across the UK, Australia, USA, and Chile under the Plasvacc brand.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersPenrith, United Kingdom
HQ citystring
Penrith
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
equine plasma products, veterinary biologicals, hyperimmunised plasma, veterinary diagnostics, animal plasma therapy
Industry3 codes
PRIMARYHLAMAEAK
Biologics & Immunotherapies (Non-vaccine)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAAAAAI
Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAMAKAD
Equine Vaccines
SIC code2 codes
  • Biological Products, (No Disgnostic Substances)2836
  • In Vitro & In Vivo Diagnostic Substances2835
Product category
Veterinary Biologics
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Plasma Biologics Sales
TypeOne Time License
Description

Sale of hyperimmunised plasma products (Hypermune™, Hypermune™-RE) for veterinary use. Products are sold as one-time purchases for plasma therapy administration. Veterinary biologics company selling cell-free plasma for natural healing in animals.

plasvacc.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Hypermune™
Description

High gamma globulin (IgG), cell-free plasma biologics product for animals, particularly equine applications.

plasvacc.com
+1 more record
Core offering1 text field

Veterinary Immunogenics manufactures and supplies hyperimmunised equine blood plasma products (Hypermune™ and Hypermune™-RE) with high gamma globulin (IgG) content for natural antibody-based healing in animals. The company also offers canine and feline diagnostic kits. All plasma products are 100% traceable, single-source donor, never-blended, and collected from a Veterinary Medicines Directorate (VMD) approved herd.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Higher IgG levels guaranteed compared to non-hyperimmunised plasma products
Product overview1 text field

Veterinary Immunogenics is a veterinary biological products company specializing in hyperimmunized blood plasma products. The core offering consists of Hypermune™ and Hypermune™-RE equine plasma products, which are 100% traceable, single-source donor, cell-free plasma with high IgG antibody levels. The company also offers Canine & Feline Diagnostic Kits. All products are supported by plasma therapy methodology including collection processes, donor herd management, and purity/safety protocols.

Product and service1 record
1Hypermune™ Products
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
1American Association of Equine Practitioners (AAEP)
Strategic tierMinorTypeOthers
Description

Professional membership organization for equine veterinarians. Veterinary Immunogenics is a proud member, demonstrating industry engagement and alignment with equine veterinary standards.

plasvacc.com
Strategic tierMinorTypeOthers
Description

Professional membership organization for equine veterinary technicians. Company membership demonstrates commitment to the broader equine veterinary professional community.

3Association of Veterinary Homeopathy (AVH)
Strategic tierMinorTypeOthers
Description

Professional organization for veterinary homeopathy practitioners. Company membership indicates alignment with holistic and complementary veterinary approaches.

plasvacc.com
Strategic tierMinorTypeOthers
Description

Professional organization for veterinary emergency and critical care. Company membership supports engagement with specialists in urgent animal care settings.

Strategic tierMinorTypeOthers
Description

UK-based professional organization for equine veterinarians. Membership aligns the company with UK equine veterinary standards and professional community.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Major animal health company with equine and livestock biologic product lines. Broad incumbent — comparable end customers (veterinarians and equine owners) and an overlapping biologics portfolio, though much larger and broader in scope.

TypeBroad incumbent
Description

Independent animal health company focused on veterinary pharmaceuticals and biologicals, with equine products. Broad incumbent — comparable in serving equine practitioners and offering biologic/therapeutic products, though diversified across species and geographies.

TypeBroad incumbent
Description

Animal health division of Merck with equine vaccines, antiparasiticides, and biologics. Broad incumbent — same end customers (equine veterinarians) and an overlapping biologics portfolio, with vastly larger R&D and global commercial reach.

4VetStem Biopharma
TypeEmerging player
Description

Veterinary regenerative medicine company providing autologous stem cell therapies primarily for equine and canine patients. Emerging player — comparable specialty veterinary biologics business serving equine practices, though using cellular rather than plasma-based therapy.

TypeEmerging player
Description

Veterinary cancer immunotherapy company offering autologous and biologic treatment products sold through veterinary practices. Emerging player — comparable specialty-veterinary biologic positioning and direct-to-veterinarian sales model, though focused on oncology rather than plasma-based antibody therapy.

TypeBroad incumbent
Description

Largest pure-play animal health company globally, with equine vaccines, parasiticides, and biologics. Broad incumbent — operates in the same equine and veterinary biologics space but at much greater scale and with a diversified portfolio rather than a single-product focus.

7Patterson Veterinary Supply
TypeBroad incumbent
Description

Major US veterinary distributor supplying pharmaceuticals, biologics, and equipment to equine and companion animal practices. Broad incumbent — serves as a potential distribution channel for veterinary biologics like Hypermune™ and competes indirectly by aggregating competing products.

TypeBroad incumbent
Description

Specialty veterinary pharmaceuticals company with a meaningful equine and companion-animal therapeutics portfolio. Broad incumbent — shares Veterinary Immunogenics' specialty veterinary therapeutics positioning and direct-to-veterinarian GTM motion, but at far greater scale across multiple therapeutic categories.

TypeBroad incumbent
Description

Leading veterinary diagnostics company whose in-clinic diagnostic kits overlap with Veterinary Immunogenics' canine and feline diagnostic kit offering. Broad incumbent — comparable in veterinary diagnostic delivery but operates at global scale across many modalities.

TypeDirect peer
Description

US-based producer of hyperimmune plasma products for animals (including equine), using single-donor and immunised donor protocols. Direct peer — same core product category (hyperimmune plasma biologics), same equine and broader animal-health customer base, and similar regulatory-driven manufacturing model.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Veterinary Immunogenics

Veterinary Biologicsveterinaryimmunogenics.com

Veterinary Immunogenics Ltd manufactures hyperimmunised equine plasma biologics (Hypermune™) and small animal diagnostic kits, selling directly to veterinarians across the UK, Australia, USA, and Chile under the Plasvacc brand.

What Veterinary Immunogenics does

Veterinary Immunogenics Ltd, operating under the Plasvacc UK brand, is a privately held veterinary biological products manufacturer founded in 1992 and headquartered in Penrith, Cumbria, United Kingdom. The company specialises in hyperimmunised equine plasma biologics marketed under the Hypermune™ and Hypermune™-RE trademarks, which are cell-free plasma products with elevated IgG antibody levels derived from a Veterinary Medicines Directorate (VMD) approved donor herd. Plasma is collected using pheresing equipment and controls comparable to those used in human blood product collection, and each product label displays measured IgG content to guarantee higher antibody levels than non-hyperimmunised alternatives. The differentiated input is 100% single-source, never-blended donor plasma, providing full traceability from donor animal to patient.

The company also offers Canine & Feline Diagnostic Kits as an add-on product line, extending its reach from equine practitioners to small animal veterinarians. Its go-to-market is sales-led, with direct ordering via phone and website contact form rather than distributor or retail channels, and technical support is delivered by experienced veterinarians who use VIL products in their own practices. Veterinary Immunogenics operates in four countries — the UK, Australia, USA, and Chile — under the unified Plasvacc brand, and is a member of five major veterinary and equine professional associations (AAEP, AAEVT, AVH, VECCS, BEVA). Revenue is generated through one-time purchases of plasma biologics and diagnostic kits, with pricing not publicly disclosed.

Veterinary Immunogenics firmographics

Firmographics
Name
Veterinary Immunogenics
Legal name
Veterinary Immunogenics Ltd
Website
https://veterinaryimmunogenics.com
Company type
Private
Founded year
1992
Operating status
Operating
Headcount range
1–10 employees
Short description
Veterinary Immunogenics Ltd manufactures hyperimmunised equine plasma biologics (Hypermune™) and small animal diagnostic kits, selling directly to veterinarians across the UK, Australia, USA, and Chile under the Plasvacc brand.
Ownership category
akta.pro rank

Veterinary Immunogenics industry classification

Industry
Product category
Veterinary Biologics
SIC
Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835)
akta.pro industry
PRIMARYHLAMAEAK
Biologics & Immunotherapies (Non-vaccine)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAAAAAI
Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors)
Healthcare & Life Sciences/Biotechnology & Biologics/Therapeutic Biologics (mAbs, recombinant proteins, cytokines)
SECONDARYHLAMAKAD
Equine Vaccines

Keywords

  • Equine plasma products
  • Veterinary biologicals
  • Hyperimmunised plasma
  • Veterinary diagnostics
  • Animal plasma therapy

Where Veterinary Immunogenics is headquartered

Location

Headquarters

HQ city
Penrith
HQ country
United Kingdom
HQ region
Europe

Offices1 record

Markets served

Veterinary Immunogenics business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Plasma Biologics Sales: Sale of hyperimmunised plasma products (Hypermune™, Hypermune™-RE) for veterinary use. Products are sold as one-time purchases for plasma therapy administration. Veterinary biologics company selling cell-free plasma for natural healing in animals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Veterinary Immunogenics product offering

Product offering

Core offering

Veterinary Immunogenics manufactures and supplies hyperimmunised equine blood plasma products (Hypermune™ and Hypermune™-RE) with high gamma globulin (IgG) content for natural antibody-based healing in animals. The company also offers canine and feline diagnostic kits. All plasma products are 100% traceable, single-source donor, never-blended, and collected from a Veterinary Medicines Directorate (VMD) approved herd.

Product overview

Veterinary Immunogenics is a veterinary biological products company specializing in hyperimmunized blood plasma products. The core offering consists of Hypermune™ and Hypermune™-RE equine plasma products, which are 100% traceable, single-source donor, cell-free plasma with high IgG antibody levels. The company also offers Canine & Feline Diagnostic Kits. All products are supported by plasma therapy methodology including collection processes, donor herd management, and purity/safety protocols.

Differentiator

Problem solved

Functional benefit

Brands

  • Hypermune™: High gamma globulin (IgG), cell-free plasma biologics product for animals, particularly equine applications.
  • Hypermune™-RE

Products and services

  • Hypermune™ Products

Quantifiable outcome

  • Higher IgG levels guaranteed compared to non-hyperimmunised plasma products

Companies that use Veterinary Immunogenics

Customer profile

Segments2 records

Ideal customer profiles2 records

Veterinary Immunogenics technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Veterinary Immunogenics partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered minor.

  • American Association of Equine Practitioners (AAEP)minorOthersProfessional membership organization for equine veterinarians. Veterinary Immunogenics is a proud member, demonstrating industry engagement and alignment with equine veterinary standards.
  • American Association of Equine Veterinary Technicians (AAEVT)minorOthersProfessional membership organization for equine veterinary technicians. Company membership demonstrates commitment to the broader equine veterinary professional community.
  • Association of Veterinary Homeopathy (AVH)minorOthersProfessional organization for veterinary homeopathy practitioners. Company membership indicates alignment with holistic and complementary veterinary approaches.
  • Veterinary Emergency and Critical Care Society (VECCS)minorOthersProfessional organization for veterinary emergency and critical care. Company membership supports engagement with specialists in urgent animal care settings.
  • British Equine Veterinary Association (BEVA)minorOthersUK-based professional organization for equine veterinarians. Membership aligns the company with UK equine veterinary standards and professional community.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Veterinary Immunogenics competitors and assessment

Company assessment

Broad incumbents

  • Elanco Animal Health: Major animal health company with equine and livestock biologic product lines. Broad incumbent — comparable end customers (veterinarians and equine owners) and an overlapping biologics portfolio, though much larger and broader in scope.
  • Vetoquinol: Independent animal health company focused on veterinary pharmaceuticals and biologicals, with equine products. Broad incumbent — comparable in serving equine practitioners and offering biologic/therapeutic products, though diversified across species and geographies.
  • Merck Animal Health (MSD Animal Health): Animal health division of Merck with equine vaccines, antiparasiticides, and biologics. Broad incumbent — same end customers (equine veterinarians) and an overlapping biologics portfolio, with vastly larger R&D and global commercial reach.
  • Zoetis: Largest pure-play animal health company globally, with equine vaccines, parasiticides, and biologics. Broad incumbent — operates in the same equine and veterinary biologics space but at much greater scale and with a diversified portfolio rather than a single-product focus.
  • Patterson Veterinary Supply: Major US veterinary distributor supplying pharmaceuticals, biologics, and equipment to equine and companion animal practices. Broad incumbent — serves as a potential distribution channel for veterinary biologics like Hypermune™ and competes indirectly by aggregating competing products.
  • Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company with a meaningful equine and companion-animal therapeutics portfolio. Broad incumbent — shares Veterinary Immunogenics' specialty veterinary therapeutics positioning and direct-to-veterinarian GTM motion, but at far greater scale across multiple therapeutic categories.
  • IDEXX Laboratories: Leading veterinary diagnostics company whose in-clinic diagnostic kits overlap with Veterinary Immunogenics' canine and feline diagnostic kit offering. Broad incumbent — comparable in veterinary diagnostic delivery but operates at global scale across many modalities.

Emerging players

  • VetStem Biopharma: Veterinary regenerative medicine company providing autologous stem cell therapies primarily for equine and canine patients. Emerging player — comparable specialty veterinary biologics business serving equine practices, though using cellular rather than plasma-based therapy.
  • Torigen Pharmaceuticals: Veterinary cancer immunotherapy company offering autologous and biologic treatment products sold through veterinary practices. Emerging player — comparable specialty-veterinary biologic positioning and direct-to-veterinarian sales model, though focused on oncology rather than plasma-based antibody therapy.

Direct peers

  • Lake Immunogenics: US-based producer of hyperimmune plasma products for animals (including equine), using single-donor and immunised donor protocols. Direct peer — same core product category (hyperimmune plasma biologics), same equine and broader animal-health customer base, and similar regulatory-driven manufacturing model.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Veterinary Immunogenics social profiles

Digital presence

Veterinary Immunogenics compliance and trust

Trust signal

Compliance1 record

Veterinary Immunogenics financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Veterinary Immunogenics leadership team

Management profile

Number of profiles

Veterinary Immunogenics funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Veterinary Immunogenics M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Veterinary Immunogenics

What does Veterinary Immunogenics do?

Veterinary Immunogenics manufactures and supplies hyperimmunised equine blood plasma products (Hypermune™ and Hypermune™-RE) with high gamma globulin (IgG) content for natural antibody-based healing in animals. The company also offers canine and feline diagnostic kits. All plasma products are 100% traceable, single-source donor, never-blended, and collected from a Veterinary Medicines Directorate (VMD) approved herd.

Is Veterinary Immunogenics a public or private company?

Veterinary Immunogenics is a private company. It is classified as unknown and is currently operating.

When was Veterinary Immunogenics founded?

Veterinary Immunogenics was founded in 1992. It employs 1 to 10 people.

Where is Veterinary Immunogenics based?

Veterinary Immunogenics is headquartered in Penrith, United Kingdom, in the Europe region.

How does Veterinary Immunogenics make money?

One revenue line is on record: plasma Biologics Sales.

Who are Veterinary Immunogenics's main competitors?

Broad incumbents on record are Elanco Animal Health, Vetoquinol, Merck Animal Health (MSD Animal Health), Zoetis, Patterson Veterinary Supply, Dechra Pharmaceuticals and IDEXX Laboratories. Emerging players are VetStem Biopharma and Torigen Pharmaceuticals. Lake Immunogenics is listed as a direct peer.

Does Veterinary Immunogenics have an API?

No public API is recorded for Veterinary Immunogenics.

What industry is Veterinary Immunogenics in?

Veterinary Immunogenics's product category is Veterinary Biologics. Its primary akta.pro industry code is HLAMAEAK, Biologics & Immunotherapies (Non-vaccine), with a secondary code of HLAAAAAI, Plasma-Derived Therapeutics (immunoglobulins, albumin, clotting factors). Its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals